arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

PRO DEX INC

PDEX
$65.69 ▲ +0.41 (+0.63%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
64 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

PRO DEX INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $210.3M
Dividend Yield
Revenue Growth 14.6%
Op. Margin 15.5%
ROIC 5.0%
FCF / Share $0.48
Trailing P/E 53.4x
Price / Book 4.7x
FCF Yield 0.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.95M
↑ +14.6%
Net Income Profit after all expenses
$3.94M
↑ +20.2%
Operating Margin Operating profit as % of sales
15.5%
↓ -11.2% 69th
FCF / Share Free cash flow per share
$0.48
↓ -55.9%
Long-Term Debt Long-term obligations
$15.43M
↑ +3729.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
53
Returns
90
Financial Health
70
Cash Quality
17

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters